BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-0.42%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$137M
AUM Growth
+$137M
Cap. Flow
+$2.64M
Cap. Flow %
1.92%
Top 10 Hldgs %
73.24%
Holding
64
New
1
Increased
15
Reduced
6
Closed
4

Sector Composition

1 Healthcare 93.73%
2 Energy 3.94%
3 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STOK icon
51
Stoke Therapeutics
STOK
$1.08B
$198K 0.14%
15,000
GTHX
52
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$198K 0.14%
40,000
ISEE
53
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$144K 0.1%
15,000
IFRX icon
54
InflaRx
IFRX
$108M
$102K 0.07%
70,000
CNCE
55
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$84K 0.06%
20,000
ELTX icon
56
Elicio Therapeutics
ELTX
$172M
$62K 0.05%
54,392
LSF icon
57
Laird Superfood
LSF
$61.7M
$53K 0.04%
28,000
AWH
58
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$49K 0.04%
83,104
-20,000
-19% -$11.8K
YTEN
59
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$42K 0.03%
18,750
SIEN
60
DELISTED
Sientra, Inc.
SIEN
$34K 0.02%
40,000
AKBA icon
61
Akebia Therapeutics
AKBA
$833M
-20,000
Closed -$14K
AMRN
62
Amarin Corp
AMRN
$311M
-300,000
Closed -$987K
BIIB icon
63
Biogen
BIIB
$19.4B
-10,100
Closed -$2.13M
VNDA icon
64
Vanda Pharmaceuticals
VNDA
$279M
-50,000
Closed -$566K